Autoimmune Encephalitis Panel-CSF

This test measures specific antibodies in the CSF, such as NMDA, AMPA, GABA B receptor, VGKC, LGI1, and ASPR2.

This test is done for the following reasons:

• To diagnose autoimmune encephalitis and determine its specific subtype
• To differentiate autoimmune encephalitis from other neurological disorders
• To guide treatment decisions and monitor treatment success in patients with autoimmune encephalitis

This test may be recommended if you have:

• Neurological symptoms like seizures, memory problems, or behavioural changes
• Suspected autoimmune encephalitis based on clinical evaluation
• Unexplained neurological symptoms that may be related to an autoimmune cause

Abnormal results of this test may indicate the presence of specific autoimmune antibodies associated with autoimmune encephalitis. Further evaluation by your doctor is necessary to interpret the results and consider additional tests or treatments.

• A small amount of CSF will be collected through a lumbar puncture.
• The sample will be sent to the lab for testing.

CSF sample is collected by the healthcare provider in a hospital or clinical setting. Consult with your healthcare provider for specific recommendations and guidance.

Other tests that may be ordered alongside the Autoimmune Encephalitis Panel-CSF test include:

• Blood tests for autoantibodies: To check for autoimmune diseases associated with neurological symptoms

Autoimmune Encephalopathy Panel-CSF or Autoimmune Encephalitis Antibody Panel-CSF

Autoimmune encephalitis is a rare condition where the immune system mistakenly attacks the brain, leading to inflammation. It often presents with various neurological symptoms, such as seizures, memory problems, behavioural changes, and movement disorders. Early diagnosis is important for timely treatment and management of the condition.